CORT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

CORTCorcept Therapeutics Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

CORTCorcept Therapeutics Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CORT2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.3%▼−3.31%×0.29

Q2 FY26—▲+27.29%—

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedCORT realized, solidLLY realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedspan: CORT 97d · LLY 267dSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

CORTCorcept Therapeutics Inc

72.35▼−8.67%· post 72.35· delayed

Mkt cap$8.7BRevenue$340MQ3 FY26Revenue$761MFY25

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,367.00· delayed

After hoursNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 5 '26delayed

CORTCorcept Therapeutics Inc

LLYELI Lilly & Co

72.35▼−8.67%post 72.35delayed

Price

1,371.32▼−3.29%post 1,367.00delayed

$8.7B

Mkt cap

$1.3T

Q3 FY26$340M

Revenue

$24.4BQ3 FY26

FY25$761M

Revenue

$65.2BFY25

CORT72.35▼−8.67%vsLLY1,371.32▼−3.29%After hoursNov 5 '26delayed